Comprehensive Insights into Potential Roles of Purinergic P2 Receptors on Diseases: Signaling Pathways Involved and Potential Therapeutics
Yanshuo Guo,Tianqi Mao,Yafei Fang,Hui Wang,Jiayue Yu,Yifan Zhu,Shige Shen,Mengze Zhou,Huanqiu Li,Qinghua Hu
DOI: https://doi.org/10.1016/j.jare.2024.03.027
IF: 12.822
2024-01-01
Journal of Advanced Research
Abstract:BackgroundPurinergic P2 receptors, which can be divided into ionotropic P2X receptors and metabotropic P2Y receptors, mediate cellular signal transduction of purine or pyrimidine nucleoside triphosphates and diphosphate. Based on the wide expression of purinergic P2 receptors in tissues and organs, their significance in homeostatic maintenance, metabolism, nociceptive transmission, and other physiological processes is becoming increasingly evident, suggesting that targeting purinergic P2 receptors to regulate biological functions and signal transmission holds significant promise for disease treatment.Aim of reviewThis review highlights the detailed mechanisms by which purinergic P2 receptors engage in physiological and pathological progress, as well as providing prospective strategies for discovering clinical drug candidates.Key scientific concepts of reviewThe purinergic P2 receptors regulate complex signaling and molecular mechanisms in nervous system, digestive system, immune system and as a result, controlling physical health states and disease progression. There has been a significant rise in research and development focused on purinergic P2 receptors, contributing to an increased number of drug candidates in clinical trials. A few influential pioneers have laid the foundation for advancements in the evaluation, development, and of novel purinergic P2 receptors modulators, including agonists, antagonists, pharmaceutical compositions and combination strategies, despite the different scaffolds of these drug candidates. These advancements hold great potential for improving therapeutic outcomes by specifically targeting purinergic P2 receptors.